Posted inClinical Updates Critical Care news Respiratory
Modulation of Respiratory Drive by Ondansetron in Acute Respiratory Distress Syndrome: Emerging Evidence and Clinical Implications
Ondansetron, a 5-HT3 antagonist, reduces respiratory drive in ARDS patients on mechanical ventilation by attenuating pulmonary C-fiber mediated stimulation, potentially lessening lung injury and improving oxygenation.
